Stability data of extemporaneous oral suspension of pentobarbital in Syrspend SF Alka for imaging sedation procedure.

Benjamin Querin, Arnaud Schweitzer-Chaput, Chahrazed Nedjar, Joël Schlatter

Open access · goldAbstract read

In one paragraph

Article in Data in brief, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 98% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Benjamin QuerinHôpital universitaire Necker - Enfants Malades, Assistance Publique des Hôpitaux de Paris (AP-HP), 149 rue de Sèvres, Paris, France.

Arnaud Schweitzer-ChaputHôpital universitaire Necker - Enfants Malades, Assistance Publique des Hôpitaux de Paris (AP-HP), 149 rue de Sèvres, Paris, France.

Chahrazed NedjarHôpital universitaire Necker - Enfants Malades, Assistance Publique des Hôpitaux de Paris (AP-HP), 149 rue de Sèvres, Paris, France.

Joël SchlatterHôpital Paul-Doumer, Assistance Publique des Hôpitaux de Paris (AP-HP), 1 rue de l'hôpital, Liancourt, France.

Assistance Publique – Hôpitaux de Paris · FRHôpital Necker-Enfants Malades · FRHôpital Paul-Doumer · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pentobarbital is used as an alternative in pediatric sedative imaging procedures. Pentobarbital is only available as pharmaceutical powder. Regardless of its clinical use, its manipulation is necessary byhospital pharmacists that must prepare adapted dosage forms for pediatrics. The data presented in this article suggest that extemporaneous suspensions of sodium pentobarbital in oral liquid base are stable for at least 120 days.

Indexed as

ImagingOral suspensionPediatricPentobarbital sodiumSedationStability

Identifiers

PMID33681434

DOI10.1016/j.dib.2021.106884

PMCPMC7910507

OpenAlexW3130524794

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.